4.17
price up icon3.99%   0.16
after-market Handel nachbörslich: 4.16 -0.010 -0.24%
loading

Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten

pulisher
Jun 21, 2026

ORMP SEC FilingsOramed Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 21, 2026
pulisher
Jun 18, 2026

Daily Brief United States: Tesla , Adobe Systems, Nine Energy Service , Oramed Pharmaceuticals , Olin Corp, Earth Science Tech, Kardigan, Generac Holdings, General Motors, Nucor Corp and more - Smartkarma

Jun 18, 2026
pulisher
Jun 18, 2026

ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community - Yahoo Finance

Jun 18, 2026
pulisher
Jun 18, 2026

Oramed Pharmaceuticals Inc (ORMP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Oramed Pharmaceuticals Inc (ORMP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Oramed Pharmaceuticals Inc (ORMP) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals Inc (ORMP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals Inc (ORMP) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals Inc (ORMP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed (ORMP) Set to Join Russell 2000 and 3000 Indexes in 2026 - GuruFocus

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals Inc (ORMP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals Inc (ORMP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals Inc - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals to join Russell 2000, 3000 indexes - Investing.com

Jun 17, 2026
pulisher
Jun 17, 2026

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes - PR Newswire

Jun 17, 2026
pulisher
Jun 15, 2026

June 2026 Penny Stocks To Watch For Potential Growth - Yahoo Finance

Jun 15, 2026
pulisher
Jun 15, 2026

These healthcare stocks are combining strong gains with reasonable prices - MSN

Jun 15, 2026
pulisher
Jun 08, 2026

Daily Brief Health Care: Parabilis Medicines, Integral Diagnostics, Healthequity Inc, ICON PLC, KT Medical Service, Leong Guan Holdings, Oramed Pharmaceuticals , Otsuka Holdings, Crism Therapeutics, TransCode Therapeutics and more - Smartkarma

Jun 08, 2026
pulisher
Jun 05, 2026

Oramed Pharmaceuticals (ORMP) Faces Selling Pressure; Key Levels in FocusTriple Bottom - newsline.com

Jun 05, 2026
pulisher
Jun 03, 2026

Oramed Pharmaceuticals Q4 2025 Earnings: Positive EPS Surprise Driven by Non-Operating IncomeEarnings Beat Alert - newsline.com

Jun 03, 2026
pulisher
May 30, 2026

Oramed Pharmaceuticals Inc. (ORMP) Q4 2025 Earnings: Surprise Profitability on Milestone RevenueEarnings Expansion Phase - newsline.com

May 30, 2026
pulisher
May 29, 2026

ORMP Should I Buy - Intellectia AI

May 29, 2026
pulisher
May 28, 2026

Oramed Pharmaceuticals (ORMP) Holds Near Key Support Amid Modest DeclineDemand Zone - The Legal Advocate

May 28, 2026
pulisher
May 26, 2026

Type 2 Diabetes Pipeline 2026: FDA Updates, Therapy - openPR.com

May 26, 2026
pulisher
May 23, 2026

Oramed Pharmaceuticals (ORMP) Drops 8.9%: Support Level Under PressureNAAIM Exposure - The Legal Advocate

May 23, 2026
pulisher
May 22, 2026

Oramed Pharmaceuticals: 'Hold' On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction - Seeking Alpha

May 22, 2026
pulisher
May 21, 2026

Oramed Pharmaceuticals (ORMP) Q4 2025 Results Meet Expectations — Revenue $N/AMargin Compression Risk - newsline.com

May 21, 2026
pulisher
May 20, 2026

Oramed Pharmaceuticals Inc. Q1 2026 Financial Report: Key Investments, Marketable Securities, and Forward-Looking Statements - Minichart

May 20, 2026
pulisher
May 19, 2026

Oramed: Q1 Earnings Snapshot - marketscreener.com

May 19, 2026
pulisher
May 19, 2026

ORAMED PHARMACEUTICALS INC. 1Q 2026: Revenue $0 Net income $38.31M, EPS $0.91— 10-Q Summary - TradingView

May 19, 2026
pulisher
May 19, 2026

Oramed (NASDAQ: ORMP) swings to $38.3M Q1 profit on Alpha Tau and Scilex gains - Stock Titan

May 19, 2026
pulisher
May 19, 2026

Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 19, 2026
pulisher
May 18, 2026

Lifeward Ltd.16079622026 - SEC.gov

May 18, 2026
pulisher
May 15, 2026

Oramed Pharmaceuticals (ORMP) Q4 2025 Financial OverviewIncome Pick - newser.com

May 15, 2026
pulisher
May 15, 2026

Oramed Pharmaceuticals Delays Quarterly SEC Filing - TipRanks

May 15, 2026
pulisher
May 15, 2026

Oramed Pharmaceuticals (NASDAQ: ORMP) notifies late Q1 2026 Form 10-Q filing - Stock Titan

May 15, 2026
pulisher
May 15, 2026

About Us | Oil & Gas JournalOramed Pharmaceuticals Inc.Common Stock (Nasdaq:ORMP) Stock Quote - FinancialContent

May 15, 2026
pulisher
May 15, 2026

Oramed Pharmaceuticals (ORMP) Stock: Slides -0.74%, Support at $4.46 2026-05-15Buy Signals - newser.com

May 15, 2026
pulisher
May 15, 2026

Aquamarine reports 5.06% stake in Oramed (ORMP) via Schedule 13G - Stock Titan

May 15, 2026
pulisher
May 14, 2026

Oramed Pharmaceuticals Discloses Investment at Lifeward with 49.9% Stake - TradingView

May 14, 2026
pulisher
May 14, 2026

Oramed details Lifeward (LFWD) equity stake, notes and warrants - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Oramed (LFWD) reports 49.9% Lifeward stake, $9M notes and warrants - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Oramed Pharmaceuticals stock (US68403P1003): Oral drug delivery innovator for US diabetes market - AD HOC NEWS

May 14, 2026
pulisher
May 13, 2026

Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks - Yahoo Finance

May 13, 2026
pulisher
May 12, 2026

Oramed Pharmaceuticals stock (US68403P1003): Shares surged 7.98% to $2.30 - AD HOC NEWS

May 12, 2026
pulisher
May 12, 2026

TradingKey - TradingKey

May 12, 2026
pulisher
May 11, 2026

MSN Money - MSN

May 11, 2026
pulisher
May 01, 2026

ORMP News | ORAMED PHARMACEUTICALS INC (NASDAQ:ORMP) - ChartMill

May 01, 2026
pulisher
Apr 27, 2026

NNDM stock in focus: Nano Dimension pops a poison pill days after Oramed stake build-up - MSN

Apr 27, 2026
$90.62
price up icon 0.48%
$32.21
price up icon 3.07%
$61.00
price up icon 2.79%
$55.35
price up icon 3.32%
ONC ONC
$276.13
price up icon 1.59%
$169.51
price up icon 2.23%
Kapitalisierung:     |  Volumen (24h):